Skip header and navigation

Narrow By

52 records – page 2 of 3.

Déclenchement artificiel du travail et maturation cervicale au moyen de comprimés oraux de misoprostol (prostaglandine E1) (Cytotec)

https://libcat.nshealth.ca/en/permalink/chpams35880
Nova Scotia Health Authority. Yarmouth Regional Hospital. Women and Children's Health Unit. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
1816
Available Online
View Pamphlet
Le misoprostol est une pilule qui contient un médicament appelé prostaglandine E1. La prostaglandine E1 assouplit le col de l’utérus pour le préparer au travail et déclencher des contractions. Cytotec® est le nom de marque de ce médicament. Le présent dépliant explique à quoi s'attendre si vous prenez du misoprostol, les complications possibles et quand informer un membre de votre équipe de soins de santé. ; This pamphlet is a French translation of "Induction of Labour and Cervical Ripening wit…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Yarmouth Regional Hospital. Women and Children's Health Unit
Alternate Title
Induction of labour and cervical ripening with oral misoprostol (prostaglandin E1) (Cytotec®)
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
French
Physical Description
1 electronic document ([2] p.) : digital, PDF file
Subjects (MeSH)
Labor, Induced
Cervical Ripening
Misoprostol
Subjects (LCSH)
Labor (Obstetrics)
Specialty
Gynecology
Abstract
Le misoprostol est une pilule qui contient un médicament appelé prostaglandine E1. La prostaglandine E1 assouplit le col de l’utérus pour le préparer au travail et déclencher des contractions. Cytotec® est le nom de marque de ce médicament. Le présent dépliant explique à quoi s'attendre si vous prenez du misoprostol, les complications possibles et quand informer un membre de votre équipe de soins de santé.
This pamphlet is a French translation of "Induction of Labour and Cervical Ripening with Oral Misoprostol (Prostaglandin E1) (Cytotec®)" pamphlet 1771. Misoprostol is a pill that contains a medication called prostaglandin E1. Prostaglandin E1 softens the cervix to get it ready for labour and to cause labour contractions. Cytotec® is the brand name of this medication. This pamphlet explains what to expect when you get misoprostol, possible complications of misoprostol, and when you should notify a member of your health care team.
Responsibility
Prepared by: Women and Children's Health Unit
Pamphlet Number
1816
Less detail

Maturation cervicale au moyen du gel vaginal de dinoprostone (Prostin)

https://libcat.nshealth.ca/en/permalink/chpams35881
Nova Scotia Health Authority. Women and Children's Health. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
1817
Available Online
View Pamphlet
ProstinMD est un gel. Il contient un médicament appelé dinoprostone (prostaglandine E2). La dinoprostone PGE2 (ou gel ProstinMD) est comme une substance naturelle produite par votre corps. Elle assouplit le col de l’utérus pour le préparer au travail. Le présent dépliant explique à quoi vous attendre comme suite à l’utilisation du gel ProstinMD, les complications possibles et quand appeler l’hôpital ou y retourner. ; This pamphlet is a French translation of "Cervical Ripening with Dinoprostone …
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Women and Children's Health
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
French
Physical Description
1 electronic document ([2] p.) : digital, PDF file
Subjects (MeSH)
Cervical Ripening
Dinoprostone
Subjects (LCSH)
Labor, Induced (Obstetrics)
Specialty
Gynecology
Abstract
ProstinMD est un gel. Il contient un médicament appelé dinoprostone (prostaglandine E2). La dinoprostone PGE2 (ou gel ProstinMD) est comme une substance naturelle produite par votre corps. Elle assouplit le col de l’utérus pour le préparer au travail. Le présent dépliant explique à quoi vous attendre comme suite à l’utilisation du gel ProstinMD, les complications possibles et quand appeler l’hôpital ou y retourner.
This pamphlet is a French translation of "Cervical Ripening with Dinoprostone Vaginal Gel (Prostin®)" pamphlet 1772. Prostin® is a gel. It contains medication called dinoprostone (prostaglandin E2). Dinoprostone PGE2 (or Prostin®) is like a natural substance made by your body. It softens the cervix to get it ready for labour. This pamphlet explains what to expect when you get Prostin®, possible complications of Prostin®, and when you should call or return to the hospital.
Responsibility
Prepared by: Women and Children's Health
Pamphlet Number
1817
Less detail

Medical abortion

https://libcat.nshealth.ca/en/permalink/chpams35888
Nova Scotia Health Authority. Nova Scotia Choice Clinic. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
1831
Available Online
View Pamphlet
This pamphlet explains what a medical abortion is, who can get a medical abortion, what happens during a medical abortion, and possible risks and side effects. Instructions for taking the medication Mifegymiso to cause a medical abortion, and who to contact for further information are included. The French version of this pamphlet 1861, "Avortement par médicaments", is also available.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Nova Scotia Choice Clinic
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Abortion, Induced
Pregnancy, Unwanted
Subjects (LCSH)
Abortion
Pregnancy, Unwanted
Specialty
Gynecology
Abstract
This pamphlet explains what a medical abortion is, who can get a medical abortion, what happens during a medical abortion, and possible risks and side effects. Instructions for taking the medication Mifegymiso to cause a medical abortion, and who to contact for further information are included. The French version of this pamphlet 1861, "Avortement par médicaments", is also available.
Responsibility
Prepared by: Nova Scotia Choice Clinic
Pamphlet Number
1831
Less detail

Procedural abortion

https://libcat.nshealth.ca/en/permalink/chpams35889
Nova Scotia Health Authority. Nova Scotia Choice Clinic. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
1832
Available Online
View Pamphlet
This pamphlet explains what a procedural abortion is, who can get a procedural abortion, what happens during a procedural abortion, and possible risks. What to expect after you go home and who to contact for further information is included. The French version of this pamphlet 1862, "Avortement par instruments", is also available.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Nova Scotia Choice Clinic
Alternate Title
Surgical abortion
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([2] p.) : digital, PDF file
Subjects (MeSH)
Abortion, Induced
Pregnancy, Unwanted
Subjects (LCSH)
Pregnancy, Unwanted
Abortion
Specialty
Gynecology
Abstract
This pamphlet explains what a procedural abortion is, who can get a procedural abortion, what happens during a procedural abortion, and possible risks. What to expect after you go home and who to contact for further information is included. The French version of this pamphlet 1862, "Avortement par instruments", is also available.
Notes
Previous title: Surgical abortion
Responsibility
Prepared by: Nova Scotia Choice Clinic
Pamphlet Number
1832
Less detail

Options for birth after cesarean

https://libcat.nshealth.ca/en/permalink/chpams35904
Nova Scotia Health Authority. Maternal Child Provincial Policy Working Group. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
1847
Available Online
View Pamphlet
If you had your baby by cesarean birth (sometimes called “cesarean delivery”, “c-section”, or “CS”), you can still have a vaginal birth in your next pregnancy. This is called a Trial of Labour after Cesarean (TOLAC) or a Vaginal Birth after Cesarean (VBAC). What makes a VBAC safe and successful, and benefits and risks of VBAC are listed. The French version of this pamphlet 1891, "Choix d’accouchement après une césarienne", is also available.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Maternal Child Provincial Policy Working Group
Alternate Title
Options for birth after caesarean section
Options for birth after cesarean section
Options for birth after c-section
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([2] p.) : digital, PDF file
Subjects (MeSH)
Vaginal Birth after Cesarean
Subjects (LCSH)
Childbirth
Specialty
Gynecology
Abstract
If you had your baby by cesarean birth (sometimes called “cesarean delivery”, “c-section”, or “CS”), you can still have a vaginal birth in your next pregnancy. This is called a Trial of Labour after Cesarean (TOLAC) or a Vaginal Birth after Cesarean (VBAC). What makes a VBAC safe and successful, and benefits and risks of VBAC are listed. The French version of this pamphlet 1891, "Choix d’accouchement après une césarienne", is also available.
Responsibility
Prepared by: Maternal Child Provincial Policy Working Group Adapted from: PL-0902 with permission of IWK Health, Halifax NS © 2015
Pamphlet Number
1847
Less detail

Avortement par médicaments

https://libcat.nshealth.ca/en/permalink/chpams35925
Nova Scotia Health Authority. Nova Scotia Choice Clinic. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
1861
Available Online
View Pamphlet
La présente brochure explique ce qu’est l’avortement par médicaments, qui peut avoir un avortement par médicaments, ce qui se passe durant l’intervention et les risques et effets secondaires possibles. Vous y trouverez des instructions pour prendre le médicament Mifegymiso afin de provoquer un avortement par médicaments et les coordonnées pour obtenir plus d'information. ; This pamphlet is a French translation of "Medical Abortion" pamphlet 1831. This pamphlet explains what a medical abortion i…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Nova Scotia Choice Clinic
Alternate Title
Medical abortion
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
French
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Abortion, Induced
Pregnancy, Unwanted
Subjects (LCSH)
Pregnancy, Unwanted
Abortion
Specialty
Gynecology
Abstract
La présente brochure explique ce qu’est l’avortement par médicaments, qui peut avoir un avortement par médicaments, ce qui se passe durant l’intervention et les risques et effets secondaires possibles. Vous y trouverez des instructions pour prendre le médicament Mifegymiso afin de provoquer un avortement par médicaments et les coordonnées pour obtenir plus d'information.
This pamphlet is a French translation of "Medical Abortion" pamphlet 1831. This pamphlet explains what a medical abortion is, who can get a medical abortion, what happens during a medical abortion, and possible risks and side effects. Instructions for taking the medication Mifegymiso to cause a medical abortion, and who to contact for further information are included.
Notes
Previous title: Avortement médicamenteux
Responsibility
Prepared by: Nova Scotia Choice Clinic
Pamphlet Number
1861
Less detail

Avortement par instruments

https://libcat.nshealth.ca/en/permalink/chpams35931
Nova Scotia Health Authority. Nova Scotia Choice Clinic. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
1862
Available Online
View Pamphlet
La présente brochure explique ce qu’est l’avortement par instruments, qui peut avoir un avortement par instruments, ce qui se passe durant l’intervention et les risques possibles. On y indique ce à quoi vous attendre après votre retour à la maison et qui contacter pour de plus amples renseignements. ; This pamphlet is a French translation of "Procedural Abortion" pamphlet 1832. This pamphlet explains what a procedural abortion is, who can get a procedural abortion, what happens during a procedu…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Nova Scotia Choice Clinic
Alternate Title
Procedural abortion
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
French
Physical Description
1 electronic document ([2] p.) : digital, PDF file
Subjects (MeSH)
Abortion, Induced
Pregnancy, Unwanted
Subjects (LCSH)
Pregnancy, Unwanted
Abortion
Specialty
Gynecology
Abstract
La présente brochure explique ce qu’est l’avortement par instruments, qui peut avoir un avortement par instruments, ce qui se passe durant l’intervention et les risques possibles. On y indique ce à quoi vous attendre après votre retour à la maison et qui contacter pour de plus amples renseignements.
This pamphlet is a French translation of "Procedural Abortion" pamphlet 1832. This pamphlet explains what a procedural abortion is, who can get a procedural abortion, what happens during a procedural abortion, and possible risks. What to expect after you go home and who to contact for further information is included.
Notes
Previous title: Avortement chirurgical
Responsibility
Prepared by: Nova Scotia Choice Clinic
Pamphlet Number
1862
Less detail

Medical abortion (Mifegymiso) instructions

https://libcat.nshealth.ca/en/permalink/chpams35935
Nova Scotia Health Authority. Nova Scotia Choice Clinic. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
1878
Available Online
View Pamphlet
This pamphlet explains how to take the medication Mifegymiso to cause an abortion. It lists the supplies you will need, how to take the medications, and symptoms that require you to call the Nova Scotia Choice Clinic Nursing Line. Information about sex and birth control after taking Mifegymiso, and follow-up care is provided. The French version of this pamphlet 1886, "Directives pour un avortement par médicaments (Mifegymiso)," is also available.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Nova Scotia Choice Clinic
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([2] p.) : digital, PDF file
Subjects (MeSH)
Abortion, Induced
Pregnancy, Unwanted
Subjects (LCSH)
Abortion
Pregnancy, Unwanted
Specialty
Gynecology
Abstract
This pamphlet explains how to take the medication Mifegymiso to cause an abortion. It lists the supplies you will need, how to take the medications, and symptoms that require you to call the Nova Scotia Choice Clinic Nursing Line. Information about sex and birth control after taking Mifegymiso, and follow-up care is provided. The French version of this pamphlet 1886, "Directives pour un avortement par médicaments (Mifegymiso)," is also available.
Responsibility
Prepared by: Nova Scotia Choice Clinic
Pamphlet Number
1878
Less detail

Directives pour un avortement par médicaments (Mifegymiso)

https://libcat.nshealth.ca/en/permalink/chpams36444
Nova Scotia Health Authority. Nova Scotia Choice Clinic. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
1886
Available Online
View Pamphlet
Ce dépliant explique comment prendre le médicament Mifegymiso pour provoquer un avortement. Il précise de quoi vous aurez besoin, la façon de prendre le médicament et les symptômes pour lesquels il faut appeler la ligne téléphonique des infirmières de la Nova Scotia Choice Clinic. Vous trouverez également des renseignements sur les relations sexuelles, sur la contraception après l'utilisation du médicament Mifegymiso et sur les soins de suivi. ; This is a French translation of the English pamph…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Nova Scotia Choice Clinic
Alternate Title
Medical abortion (Mifegymiso) instructions
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
French
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Abortion, Induced
Subjects (LCSH)
Abortion
Specialty
Gynecology
Abstract
Ce dépliant explique comment prendre le médicament Mifegymiso pour provoquer un avortement. Il précise de quoi vous aurez besoin, la façon de prendre le médicament et les symptômes pour lesquels il faut appeler la ligne téléphonique des infirmières de la Nova Scotia Choice Clinic. Vous trouverez également des renseignements sur les relations sexuelles, sur la contraception après l'utilisation du médicament Mifegymiso et sur les soins de suivi.
This is a French translation of the English pamphlet 1878, “Medical abortion (Mifegymiso) instructions.” This pamphlet explains how to take the medication Mifegymiso to cause an abortion. It lists the supplies you will need, how to take the medications, and symptoms that require you to call the Nova Scotia Choice Clinic Nursing Line. Information about sex and birth control after taking Mifegymiso, and follow-up care is provided.
Notes
Previous title: Directives pour un avortement médicamenteux (Mifegymiso)
Responsibility
Prepared by: Nova Scotia Choice Clinic
Pamphlet Number
1886
Less detail

Après votre intervention

https://libcat.nshealth.ca/en/permalink/chpams36741
Nova Scotia Health Authority. Nova Scotia Choice Clinic. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
2109
Available Online
View Pamphlet
Le dépliant fournit des instructions à suivre après votre avortement, dont une liste des choses à éviter pendant 24 heures (une journée). Vous y trouverez une liste des symptômes qui exigent des soins médicaux, ainsi que de l’information sur la prévention de l’infection, le retour à la maison et les personnes à joindre si vous avez des questions. On vous propose un lien vers un questionnaire de rétroaction et les coordonnées pour obtenir du counseling gratuit. ; This pamphlet is a French transl…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Nova Scotia Choice Clinic
Alternate Title
Après votre avortement
After your procedure
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
French
Physical Description
1 electronic document ([6] p.) : digital, PDF file
Subjects (MeSH)
Abortion, Induced
Pregnancy, Unwanted
Subjects (LCSH)
Abortion
Pregnancy, Unwanted
Specialty
Gynecology
Abstract
Le dépliant fournit des instructions à suivre après votre avortement, dont une liste des choses à éviter pendant 24 heures (une journée). Vous y trouverez une liste des symptômes qui exigent des soins médicaux, ainsi que de l’information sur la prévention de l’infection, le retour à la maison et les personnes à joindre si vous avez des questions. On vous propose un lien vers un questionnaire de rétroaction et les coordonnées pour obtenir du counseling gratuit.
This pamphlet is a French translation of "After Your Procedure" pamphlet 1509. Instructions for after your abortion are given, including a list of activities to avoid for 24 hours (1 day). A list of symptoms that require medical attention is provided. Information on preventing infection, what to expect after you go home, and who to contact if you have questions is given. A link to a feedback survey and contact information for free counselling is provided.
Responsibility
Prepared by: Nova Scotia Choice Clinic
Pamphlet Number
2109
Less detail

Neonatal abstinence syndrome

https://libcat.nshealth.ca/en/permalink/chpams36769
Nova Scotia Health Authority. Women and Children's Provincial Policy Working Group. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
2144
Available Online
View Pamphlet
Neonatal abstinence syndrome (NAS) happens when a baby withdraws from medication that you have been taking during your pregnancy. This pamphlet explains the common symptoms of NAS, what your health care team will do to help your baby, what you can do to help your baby, what will happen if your baby needs medication, and when your baby can go home. The French version of this pamphlet 2203, "Syndrome de sevrage néonatal," is also available.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Women and Children's Provincial Policy Working Group
Alternate Title
NAS
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([2] p.) : digital, PDF file
Subjects (MeSH)
Neonatal Abstinence Syndrome
Subjects (LCSH)
Newborn infants--Effect of drugs on
Specialty
Gynecology
Abstract
Neonatal abstinence syndrome (NAS) happens when a baby withdraws from medication that you have been taking during your pregnancy. This pamphlet explains the common symptoms of NAS, what your health care team will do to help your baby, what you can do to help your baby, what will happen if your baby needs medication, and when your baby can go home. The French version of this pamphlet 2203, "Syndrome de sevrage néonatal," is also available.
Responsibility
Prepared by: Women and Children's Provincial Policy Working Group
Pamphlet Number
2144
Less detail

Quitting smoking to lower your risk of cervical cancer

https://libcat.nshealth.ca/en/permalink/chpams37302
Nova Scotia Health Authority. Department of Obstetrics and Gynecology. Division of Gynaecologic Oncology. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
2167
Available Online
View Pamphlet
Cervical cancer is cancer that starts in the cervix. The cervix is the lower part of the uterus (womb) that opens at the top of the vagina. This pamphlet explains how smoking increases your chance of getting cervical cancer, other reasons to quit smoking, what nicotine replacement therapy (NRT) is and how much it will cost, why e-cigarettes are not recommended, medications that are available to help you quit smoking, and other options to quit smoking. Tips for quitting smoking and a list of res…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Department of Obstetrics and Gynecology. Division of Gynaecologic Oncology
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
English
Physical Description
1 electronic document (9 p.) : digital, PDF file
Subjects (MeSH)
Smoking Cessation
Uterine Cervical Neoplasms - prevention & control
Subjects (LCSH)
Smoking cessation
Cervix uteri--Cancer--Prevention
Specialty
Gynecology
Abstract
Cervical cancer is cancer that starts in the cervix. The cervix is the lower part of the uterus (womb) that opens at the top of the vagina. This pamphlet explains how smoking increases your chance of getting cervical cancer, other reasons to quit smoking, what nicotine replacement therapy (NRT) is and how much it will cost, why e-cigarettes are not recommended, medications that are available to help you quit smoking, and other options to quit smoking. Tips for quitting smoking and a list of resources are also provided.
Responsibility
Prepared by: Department of Obstetrics and Gynecology: Division of Gynaecologic Oncology
Pamphlet Number
2167
Less detail

Internal and external condoms

https://libcat.nshealth.ca/en/permalink/chpams37442
Nova Scotia Health Authority. Nova Scotia Choice Clinic. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
1039
Available Online
View Pamphlet
Condoms are birth control devices that prevent semen (the fluid that contains sperm) from entering a vagina or anus. When semen is released inside a vagina, it may reach an egg and fertilize it, causing pregnancy. Condoms also help prevent the spread of sexually transmitted infections (STIs), including HIV, if used properly. There are 2 types of condoms: internal (worn on the inside of the vagina or anus) and external (worn on the outside of an erect penis). This pamphlet explains what internal…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Nova Scotia Choice Clinic
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
English
Physical Description
1 electronic document (6 p.) : digital, PDF file
Subjects (MeSH)
Contraception - methods
Subjects (LCSH)
Contraception
Specialty
Gynecology
Abstract
Condoms are birth control devices that prevent semen (the fluid that contains sperm) from entering a vagina or anus. When semen is released inside a vagina, it may reach an egg and fertilize it, causing pregnancy. Condoms also help prevent the spread of sexually transmitted infections (STIs), including HIV, if used properly. There are 2 types of condoms: internal (worn on the inside of the vagina or anus) and external (worn on the outside of an erect penis). This pamphlet explains what internal and external condoms are, how they work, how well they work to prevent pregnancy, what to do if a condom breaks during vaginal sex, and what to do if your partner does not want to use a condom. A link to the The Society of Obstetricians and Gynaecologists of Canada website is provided for further information.
Responsibility
Prepared by: Nova Scotia Choice Clinic
Pamphlet Number
1039
Less detail
Nova Scotia Health Authority. Nova Scotia Choice Clinic. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
0699
Available Online
View Pamphlet
A tubal ligation is a permanent form of birth control. It is commonly called "having your tubes tied". Topics include how a tubal ligation is done, how well it works, and a list of pros and cons of the procedure.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Nova Scotia Choice Clinic
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([2] p.) : digital, PDF file
Subjects (MeSH)
Sterilization, Tubal
Subjects (LCSH)
Tubal sterilization
Specialty
Gynecology
Abstract
A tubal ligation is a permanent form of birth control. It is commonly called "having your tubes tied". Topics include how a tubal ligation is done, how well it works, and a list of pros and cons of the procedure.
Responsibility
Prepared by: Nova Scotia Choice Clinic
Pamphlet Number
0699
Less detail

Syndrome de sevrage néonatal

https://libcat.nshealth.ca/en/permalink/chpams37507
Nova Scotia Health Authority. Women and Children's Provincial Policy Working Group. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
2203
Available Online
View Pamphlet
Le syndrome de sevrage néonatal (ou syndrome de sevrage du bébé) se produit lorsqu’un nouveau né est privé d’un médicament que sa mère prenait pendant sa grossesse. Ce dépliant explique les symptômes courants, ce que l’équipe de soins fera pour aider votre bébé, ce que vous pouvez faire pour aider votre bébé, ce qui se passera si votre bébé a besoin de médicaments pour traiter ses symptômes et quand votre bébé pourra rentrer à la maison. ; This pamphlet is a French translation of the English pa…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Women and Children's Provincial Policy Working Group
Alternate Title
Neonatal abstinence syndrome
NAS
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
French
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Neonatal Abstinence Syndrome
Subjects (LCSH)
Newborn infants--Effect of drugs on
Specialty
Gynecology
Abstract
Le syndrome de sevrage néonatal (ou syndrome de sevrage du bébé) se produit lorsqu’un nouveau né est privé d’un médicament que sa mère prenait pendant sa grossesse. Ce dépliant explique les symptômes courants, ce que l’équipe de soins fera pour aider votre bébé, ce que vous pouvez faire pour aider votre bébé, ce qui se passera si votre bébé a besoin de médicaments pour traiter ses symptômes et quand votre bébé pourra rentrer à la maison.
This pamphlet is a French translation of the English pamphlet 2144, "Neonatal abstinence syndrome". Neonatal abstinence syndrome (NAS) happens when a baby withdraws from medication that you have been taking during your pregnancy. This pamphlet explains the common symptoms of NAS, what your health care team will do to help your baby, what you can do to help your baby, what will happen if your baby needs medication, and when your baby can go home.
Responsibility
Prepared by: Women and Children's Provincial Policy Working Group
Pamphlet Number
2203
Less detail

How to apply your steroid ointment

https://libcat.nshealth.ca/en/permalink/chpams35603
Nova Scotia Health Authority. QEII. Gynecolposcopy Clinic. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
1607
Available Online
View Pamphlet
You have been prescribed a steroid ointment. This medication helps to lower inflammation (redness, swelling, pain) caused by a skin condition on your vulva. This 1-page sheet explains how to apply (put) your steroid ointment on your vulva. A diagram shows exactly where to apply the ointment. Tips to remember are included. The French version of this pamphlet 2111, "Comment appliquer votre onguent stéroïde", is also available.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. QEII. Gynecolposcopy Clinic
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([1] p.) : digital, PDF file
Subjects (MeSH)
Vulvar Diseases - drug therapy
Steroids - therapeutic use
Subjects (LCSH)
Steroid drugs
Vulva--Diseases
Specialty
Gynecology
Abstract
You have been prescribed a steroid ointment. This medication helps to lower inflammation (redness, swelling, pain) caused by a skin condition on your vulva. This 1-page sheet explains how to apply (put) your steroid ointment on your vulva. A diagram shows exactly where to apply the ointment. Tips to remember are included. The French version of this pamphlet 2111, "Comment appliquer votre onguent stéroïde", is also available.
Responsibility
Prepared by: Gynecolposcopy Clinic
Pamphlet Number
1607
Less detail

After vulvar biopsy or excision

https://libcat.nshealth.ca/en/permalink/chpams35624
Nova Scotia Health Authority. Central Zone. Gynecolposcopy Clinic. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
1625
Available Online
View Pamphlet
This sheet provides general skin care instructions for after a vulvar biopsy or vulvar excision.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Central Zone. Gynecolposcopy Clinic
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([1] p.) : digital, PDF file
Subjects (MeSH)
Vulvar Neoplasms - diagnosis
Vulvar Diseases - diagnosis
Subjects (LCSH)
Vulva--Diseases
Specialty
Gynecology
Abstract
This sheet provides general skin care instructions for after a vulvar biopsy or vulvar excision.
Responsibility
Prepared by: Gynecolposcopy Clinic
Pamphlet Number
1625
Less detail

Deuxième nuit du bébé

https://libcat.nshealth.ca/en/permalink/chpams36535
Nova Scotia Health Authority. Maternal Child Provincial Policy Working Group. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
1965
Available Online
View Pamphlet
La présente ressource explique les défis auxquels vous pourriez faire face 24 heures après la naissance de votre bébé. Des moyens d’apaiser votre bébé vous sont présentés. Au fur et à mesure que vous apprendrez à connaître les comportements de votre bébé, vous constaterez que c’est au sein, bien blotti contre vous, qu’il se sent le plus réconforté. ; This is a French translation of the English pamphlet 1931, “Baby's Second Night”. This pamphlet explains the challenges you may experience 24 hour…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Maternal Child Provincial Policy Working Group
Alternate Title
Baby's second night
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
French
Physical Description
1 electronic document ([2] p.) : digital, PDF file
Subjects (MeSH)
Breast Feeding
Infant, Newborn - growth & development
Kangaroo-Mother Care Method
Subjects (LCSH)
Breastfeeding
Newborn Infants
Specialty
Gynecology
Abstract
La présente ressource explique les défis auxquels vous pourriez faire face 24 heures après la naissance de votre bébé. Des moyens d’apaiser votre bébé vous sont présentés. Au fur et à mesure que vous apprendrez à connaître les comportements de votre bébé, vous constaterez que c’est au sein, bien blotti contre vous, qu’il se sent le plus réconforté.
This is a French translation of the English pamphlet 1931, “Baby's Second Night”. This pamphlet explains the challenges you may experience 24 hours after your baby is born. Ways to comfort your baby are provided. As you get to know your baby's behaviours, you will begin to see that they are most comforted by snuggling up to you at your breast/chest.
Responsibility
Prepared by: Maternal Child Provincial Policy Working Group with permission from Jan Barger RN, MA, IBCLC/Lactation Education Consultans; BFI Coordinator
Pamphlet Number
1965
Less detail

Soothers : Cape Breton Regional Hospital

https://libcat.nshealth.ca/en/permalink/chpams36752
Nova Scotia Health Authority. Cape Breton Regional Hospital. Baby Friendly Initiative. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
2289
Available Online
View Pamphlet
This pamphlet gives information about soother use. Topics include how soothers can interfere with breastfeeding, risks, tips before offering a soother, things to keep in mind if you decide to use one, and care instructions. Contact information for more support is also included.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Cape Breton Regional Hospital. Baby Friendly Initiative
Alternate Title
Pacifiers : Cape Breton Regional Hospital
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([6] p.) : digital, PDF file
Subjects (MeSH)
Pacifiers
Subjects (LCSH)
Pacifiers (Infant care)
Specialty
Gynecology
Abstract
This pamphlet gives information about soother use. Topics include how soothers can interfere with breastfeeding, risks, tips before offering a soother, things to keep in mind if you decide to use one, and care instructions. Contact information for more support is also included.
Responsibility
Prepared by: Cape Breton Regional Hospital Baby Friendly Initiative
Pamphlet Number
2289
Less detail

High blood pressure in pregnancy - South Shore Regional Hospital

https://libcat.nshealth.ca/en/permalink/chpams37588
Nova Scotia Health Authority. South Shore Regional Hospital. Women and Children's Health Program. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
2285
Available Online
View Pamphlet
High blood pressure in pregnancy (also called gestational hypertension) is a blood pressure (BP) that stays higher than 140/90 (140 over 90). For most people, a normal blood pressure is 140/90 or less. After week 20 of your pregnancy, high blood pressure can be linked to pre-eclampsia. This is a more serious condition that includes high blood pressure and protein in the urine (pee). Because pre-eclampsia can be dangerous to you and your baby, we ask you to monitor your blood pressure and sympto…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. South Shore Regional Hospital. Women and Children's Health Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
English
Physical Description
1 electronic document (5 p.) : digital, PDF file
Subjects (MeSH)
Hypertension
Pregnancy
Subjects (LCSH)
Hypertension
Pregnancy
Specialty
Gynecology
Abstract
High blood pressure in pregnancy (also called gestational hypertension) is a blood pressure (BP) that stays higher than 140/90 (140 over 90). For most people, a normal blood pressure is 140/90 or less. After week 20 of your pregnancy, high blood pressure can be linked to pre-eclampsia. This is a more serious condition that includes high blood pressure and protein in the urine (pee). Because pre-eclampsia can be dangerous to you and your baby, we ask you to monitor your blood pressure and symptoms. This pamphlet explains the symptoms to watch for if you have high blood pressure, how to check your blood pressure at home, and symptoms that require medical attention right away. Contact information for the OBS Clinic and OBS Unit, and sheets to keep track of your blood pressure are included.
Responsibility
Prepared by: South Shore Regional Hospital, Women and Children’s Health Program
Pamphlet Number
2285
Less detail

52 records – page 2 of 3.